Lumature Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$111K Buy
500
+83
+20% +$19.3K 0.07% 189
2023
Q1
$101K Buy
417
+32
+8% +$7.86K 0.06% 186
2022
Q4
$101K Buy
385
+241
+167% +$64.6K 0.06% 186
2022
Q3
$32K Buy
144
+1
+0.7% +$242 0.02% 251
2022
Q2
$35K Buy
143
+1
+0.7% +$245 0.02% 253
2022
Q1
$34K Buy
142
+48
+51% +$11K 0.01% 278
2021
Q4
$21K Buy
94
+13
+16% +$2.74K 0.01% 290
2021
Q3
$17K Sell
81
-94
-54% -$21.6K 0.01% 303
2021
Q2
$43K Buy
175
+79
+82% +$19.4K 0.02% 241
2021
Q1
$24K Buy
+96
New +$22.9K 0.01% 255

Other funds holding AMGN

Lumature Wealth Partners's AMGN Position: Q2 2023 in Review

Lumature Wealth Partners increased its Amgen (AMGN) stake by 20% in Q2 2023, buying an estimated $19.3K and bringing the position to 500 shares worth $111K. The position accounts for 0.07% of the portfolio, ranked #189.

Lumature Wealth Partners first reported a position in AMGN in Q1 2021 and has held it in 10 quarters since. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Lumature Wealth Partners held 500 shares of Amgen worth $111K as of Q2 2023.
  • Lumature Wealth Partners bought 83 Amgen shares in Q2 2023, an estimated $19.3K.
  • Amgen made up 0.07% of Lumature Wealth Partners's portfolio in Q2 2023, its #189 holding.
  • Lumature Wealth Partners first reported a position in Amgen in Q1 2021 and has held it in 10 quarters since.
  • 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.